- Home
- TPIC vs VANI Comparison
TPIC vs VANI Comparison
Compare TPIC & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPIC
- VANI
- Stock Information
- Founded
- TPIC 1968
- VANI 1998
- Country
- TPIC United States
- VANI United States
- Employees
- TPIC N/A
- VANI N/A
- Industry
- TPIC Industrial Machinery/Components
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TPIC Industrials
- VANI Health Care
- Exchange
- TPIC Nasdaq
- VANI Nasdaq
- Market Cap
- TPIC 65.6M
- VANI 65.2M
- IPO Year
- TPIC 2016
- VANI 2014
- Fundamental
- Price
- TPIC $0.81
- VANI $1.07
- Analyst Decision
- TPIC Hold
- VANI Strong Buy
- Analyst Count
- TPIC 6
- VANI 1
- Target Price
- TPIC $1.86
- VANI $4.00
- AVG Volume (30 Days)
- TPIC 890.0K
- VANI 102.7K
- Earning Date
- TPIC 05-01-2025
- VANI 03-31-2025
- Dividend Yield
- TPIC N/A
- VANI N/A
- EPS Growth
- TPIC N/A
- VANI N/A
- EPS
- TPIC N/A
- VANI N/A
- Revenue
- TPIC $1,331,131,000.00
- VANI N/A
- Revenue This Year
- TPIC $9.08
- VANI N/A
- Revenue Next Year
- TPIC $9.44
- VANI N/A
- P/E Ratio
- TPIC N/A
- VANI N/A
- Revenue Growth
- TPIC N/A
- VANI N/A
- 52 Week Low
- TPIC $0.73
- VANI $1.03
- 52 Week High
- TPIC $5.75
- VANI $2.22
- Technical
- Relative Strength Index (RSI)
- TPIC 37.74
- VANI 41.41
- Support Level
- TPIC $0.79
- VANI $1.06
- Resistance Level
- TPIC $0.87
- VANI $1.16
- Average True Range (ATR)
- TPIC 0.11
- VANI 0.04
- MACD
- TPIC -0.00
- VANI 0.01
- Stochastic Oscillator
- TPIC 14.84
- VANI 28.85
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.